Objective: The primary objective is to analyse whether LSCI could be integrated in a PAOD endovascular operation program in a HOT, for the visualisation of the microcirculation of the foot. Therefore, stability and reproducibility of the system,…
ID
Source
Brief title
Condition
- Arteriosclerosis, stenosis, vascular insufficiency and necrosis
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameters will be perfusion images and graphs of the foot
microcirculation of patients with PAOD, measured with LSCI. Stability and
reproducibility of the LSCI technique will be analysed.
Secondary outcome
- Analyse if there is a drift/arise of a system error, in the measurements
during long measurements (>1 hour)
-Environmental induced
-System induced
Background summary
Introduction: In peripheral arterial occlusive disease (PAOD) one or more
arterial stenosis, cause a change in haemodynamics. The change in haemodynamics
results in an insufficient blood supply in the legs. In end stadium PAOD this
can result in severe claudication or tissue loss. Worldwide, 200 million
patients are suffering from PAOD. To prevent tissue loss or to resolve severe
claudication, PAOD patients are treated endovascularly by means of Percutaneous
Transluminal Angioplasty (PTA), possibly supplemented with the placement of a
stent. In Medisch Spectrum Twente (MST) Enschede these endovascular procedures,
are carried out, since January 2016, in the Hybrid Operating Theatre (HOT).
Visualization of blood and oxygen delivery to the affected tissue, the
microcirculation in the patients foot, is not yet possible with the current
imaging techniques used in the HOT. Therefore, besides the conventional
fluoroscopy and angiography, a second imaging module should be present in the
PAOD endovascular operation program, that can visualise the microcirculation of
the foot, throughout the entire PTA procedure. This second imaging module will
show a peroperative outcome/effect of the endovascular treatment to the
affected tissue, which is not yet possible. Laser Speckle Contrast Imaging
(LSCI) could be the solution to provide this method of imaging to have a
visualisation of the procedure outcome peroperative.
The clinical impact of the addition of LSCI, is a better peroperative feedback
about blood flow in the target area, the foot microcirculation.
Rationale: The rationale of this research is to determine whether LSCI could be
integrated in a PAOD endovascular operation program in a HOT, for the
visualisation of the microcirculation of the foot. Therefore, stability and
reproducibility of the system, environmental factors and the influence of
general anaesthesia on the measurement outcome needs to be investigated.
Study objective
Objective: The primary objective is to analyse whether LSCI could be integrated
in a PAOD endovascular operation program in a HOT, for the visualisation of the
microcirculation of the foot. Therefore, stability and reproducibility of the
system, environmental factors and the influence of general anaesthesia on the
measurement outcome needs to be investigated.
Study design
Single centre (MST Enschede) blinded observational pilot study, followed by a
prospective observational single centre (MST Enschede) cohort study.
Study burden and risks
There are no direct benefits for the subject on short term. The subjects do
contribute to more knowledge about the treatment of PAOD, so that in the
future, patients with PAOD can be better treated. The used technique, LSCI, is
safe for the patient when applied. For the patient there are no risks
associated with LSCI.
Koningsplein 1
Enschede 7512 KZ
NL
Koningsplein 1
Enschede 7512 KZ
NL
Listed location countries
Age
Inclusion criteria
Patients with end stage PAOD (Rutherford CLI grade 4-5-6)
First/initial intervention for PAOD
Procedures performed in the HOT, MST Enschede
Procedures performed under general anaesthesia
Aged 18 years or more
Exclusion criteria
Re-interventions for PAOD
Amputation (partial) of foot or toes in medical history
Multiple drug resistance (MDR) (Dutch: BRMO)
Tattoo at the plantar side of the foot
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL66041.044.18 |
OMON | NL-OMON23881 |